Chembio Stock Valuation


USD 0.64  0.01  1.54%   

Do you want to know what the current value of Chembio Diagnostics is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Chembio Diagnostics, is its stock price multiplied by the total number of shares outstanding, calculating Chembio Diagnostics' enterprise value requires a different approach. It uses Chembio Diagnostics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Chembio Diagnostics Enterprise Value is most likely to increase significantly in the upcoming years. The preceding year's Enterprise Value was reported at 24.17 Million. The current Tangible Asset Value is estimated to increase to about 75.8 M, while Free Cash Flow is projected to decrease to (33.6 M).
Chembio Diagnostics shows a prevailing Real Value of $0.53 per share. The current price of the firm is $0.64. Chembio Diagnostics is overvalued. Our model approximates the value of Chembio Diagnostics from analyzing the firm fundamentals such as return on equity of (109.29) %, and Profit Margin of (70.90) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Chembio Diagnostics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Chembio Diagnostics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Chembio Most Recent Valuation Data

Price Book
Enterprise Value
21.1 M
Enterprise Value Ebitda
Price Sales
Forward PE
Enterprise Value Revenue
Today 0.64
Please note that Chembio Diagnostics' price fluctuation is out of control at this time. Calculation of the real value of Chembio Diagnostics is based on 3 months time horizon. Increasing Chembio Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chembio Diagnostics is useful when determining the fair value of the Chembio stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chembio Diagnostics. Since Chembio Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chembio Stock. However, Chembio Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Chembio Diagnostics helps investors to forecast how Chembio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chembio Diagnostics more accurately as focusing exclusively on Chembio Diagnostics' fundamentals will not take into account other important factors:
Estimates (1)
LowProjected EPSHigh
LowEstimated ValueHigh
LowNext ValueHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Chembio Diagnostics' intrinsic value based on its ongoing forecasts of Chembio Diagnostics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Chembio Diagnostics' closest peers. When choosing an evaluation method for Chembio Diagnostics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Chembio Valuation Drivers Correlation

Many accounts on the financial statements of Chembio Diagnostics are highly interrelated and sometimes correlated. Consequently, when conducting Chembio's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Chembio
Click cells to compare fundamentals

Chembio Valuation Trend

Knowing Chembio Diagnostics' actual value is paramount for traders to make sound investment determinations. Chembio Diagnostics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Chembio Diagnostics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Chembio Diagnostics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Chembio Market Cap

Chembio Diagnostics is number one stock in market capitalization category among related companies. Market capitalization of Diagnostics & Research industry is currently estimated at about 1.66 Trillion. Chembio Diagnostics adds roughly 18.96 Million in market capitalization claiming only tiny portion of equities under Diagnostics & Research industry.
Capitalization  Revenue  Valuation  Total debt  Workforce

Chembio Diagnostics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Chembio Diagnostics's current stock value. Our valuation model uses many indicators to compare Chembio Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chembio Diagnostics competition to find correlations between indicators driving Chembio Diagnostics's intrinsic value. More Info.
Chembio Diagnostics is number one stock in price to sales category among related companies. It is number one stock in beta category among related companies totaling about  4.10  of Beta per Price to Sales. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chembio Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chembio Diagnostics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chembio Diagnostics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chembio Diagnostics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chembio Diagnostics and how it compares across the competition.

About Chembio Diagnostics Valuation

The equity valuation mechanism determines the current worth of Chembio Diagnostics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Chembio Diagnostics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Chembio Diagnostics based exclusively on its fundamental and basic technical indicators. By analyzing Chembio Diagnostics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Chembio Diagnostics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chembio Diagnostics. We calculate exposure to Chembio Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chembio Diagnostics's related companies.
Last ReportedProjected for 2022
Gross Profit13.3 M13.3 M
Profit Margin(0.71) (0.73) 
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or diagnose diseases. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York. Chembio Diagnostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 337 people.

Chembio Diagnostics Quarterly Enterprise Value

21.73 Million


Chembio Diagnostics Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Chembio Diagnostics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.63
Revenue Growth101.20%
Enterprise Value To Ebitda-0.68
Enterprise Value To Revenue0.30

Chembio Diagnostics Current Valuation Indicators

Valuation refers to the process of determining the present value of Chembio Diagnostics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Chembio we look at many different elements of the entity such as Chembio's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Chembio Diagnostics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Chembio Diagnostics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Chembio Diagnostics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Chembio Diagnostics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Chembio Diagnostics' worth.
Continue to Trending Equities. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
19.2 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.